Switch from antagonist to agonist of the androgen receptor bicalutamide is associated with prostate tumour progression in a new model system
在一种新的模型系统中,雄激素受体拮抗剂比卡鲁胺向激动剂的转变与前列腺肿瘤进展相关。
期刊:British Journal of Cancer
影响因子:6.8
doi:10.1038/sj.bjc.6690684
Culig, Z; Hoffmann, J; Erdel, M; Eder, I E; Hobisch, A; Hittmair, A; Bartsch, G; Utermann, G; Schneider, M R; Parczyk, K; Klocker, H